FIGURE 1 -Survival after surgery of patients with NSCLC according to p53 expression level. Log-rank tests used for comparisons.
Microsatellite alterations and p53, TGFβRII, IGFIIR and BAX mutations in sporadic non-small-cell lung cancer
✍ Scribed by Maria A. Caligo; Chiara Ghimenti; Antonio Marchetti; Antonino Lonobile; Fiamma Buttitta; Silvia Pellegrini; Generoso Bevilacqua
- Publisher
- John Wiley and Sons
- Year
- 1998
- Tongue
- French
- Weight
- 76 KB
- Volume
- 78
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
✦ Synopsis
Fifty-two sporadic primary non-small-cell lung carcinomas (NSCLC) were examined for microsatellite instability. Six different microsatellite markers localized on chromosomes 2, 5, 8, 10, 11 and 17 were used. Genomic instability was observed in 35% (18/52) of NSCLC at single or multiple loci. The tumors were also analyzed for p53-gene mutations by PCR-SSCP analysis. Polynucleotide stretch frameshift mutations of TGFRII (transforming-growth-factor-beta receptor II), IGFIIR (insuline growth-factor II receptor) and BAX genes were also analyzed. RER ؉ (replication-error-positive) tumors appear not to be affected by a higher rate of point mutations in coding sequences: no correlation was found between microsatellite instability and point mutations in the p53 gene, and the RER ؉ tumors showed no alterations in stretches of nucleotide inside TGFRII,
📜 SIMILAR VOLUMES
Validated markers are needed to identify operable lung cancer patients with poor prognosis. About one-half of nonsmall-cell lung cancers (NSCLCs) carry a mutation in the p53 tumor-suppressor gene. We examined 101 NSCLC patients for surgical stage, completeness of resection, tobacco smoking, asbestos